Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Restructuring Costs: 2020-2025

Historic Restructuring Costs for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $19.8 million.

  • Cellebrite DI's Restructuring Costs rose 46.06% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.0 million, marking a year-over-year increase of 24.81%. This contributed to the annual value of $50.9 million for FY2024, which is 17.17% up from last year.
  • As of Q3 2025, Cellebrite DI's Restructuring Costs stood at $19.8 million, which was up 42.60% from $13.9 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Restructuring Costs high stood at $20.5 million for Q3 2021, and its period low was $7.0 million during Q2 2021.
  • For the 3-year period, Cellebrite DI's Restructuring Costs averaged around $12.7 million, with its median value being $11.8 million (2023).
  • Per our database at Business Quant, Cellebrite DI's Restructuring Costs surged by 205.78% in 2021 and then plummeted by 46.16% in 2022.
  • Quarterly analysis of 5 years shows Cellebrite DI's Restructuring Costs stood at $11.2 million in 2021, then dropped by 21.30% to $8.8 million in 2022, then soared by 33.41% to $11.8 million in 2023, then grew by 24.01% to $14.6 million in 2024, then skyrocketed by 46.06% to $19.8 million in 2025.
  • Its Restructuring Costs was $19.8 million in Q3 2025, compared to $13.9 million in Q2 2025 and $11.7 million in Q1 2025.